RSS feed (help)
Exceptional Circumstances Forms
Hospital & Community Exceptional Circumstances - application information & form (7 pages, 34 KB)
- Pharmaceutical Cancer Treatments Paediatric Oncology/Haematology Notification Form (1 page, 44 KB) 20 Jun 2008
- Cancer Exceptional Circumstances - application information & form (3 pages, 35 KB) 19 May 2008
- Prednisolone sodium phosphate oral liquid - application information & form (3 pages, 109 KB) 30 Apr 2008
- Propylthiouracil - application information & form (3 pages, 127 KB) 16 Apr 2008
- Ethambutol 100 mg tablets - application information & form (2 pages, 96 KB) 29 Apr 2005
Page updated on 20 Jun 2008
Linked documents
Pharmaceutical Cancer Treatments Paediatric Oncology/Haematology Notification Form (1 page, 44 KB)
Pharmaceutical Cancer Treatments Paediatric Oncology/Haematology Notification Form Return completed form to: Exceptional Circumstances Panel Coordinator Phone: Fax: 04 916 7553 09 523 6870 Patient details Last name First name Date of birth NHI number Prescribing practitioner details Last name First…
Propylthiouracil - application information & form (3 pages, 127 KB)
APPLICATION INFORMATION FOR PROPYLTHIOURACIL With the withdrawal of the Abbott brand of Propylthiouracil from the market, an alternative source of Propylthiouracil is available from Health Support Limited (HSL). As this product is being sourced from Australia, it is only available…
Ethambutol 100 mg tablets - application information & form (2 pages, 96 KB)
With the withdrawal of ethambutol 100 mg tablets from the market, an alternative brand will be funded through Exceptional Circumstances...
